Dislocation filtering in GaN by selective area growth through a nanoporous template is examined both by transmission electron microscopy and numerical modeling. These nanorods grow epitaxially from the (0001)-oriented GaN underlayer through the approximately 100 nm thick template and naturally terminate with hexagonal pyramid-shaped caps. It is demonstrated that for a certain window of geometric parameters a threading dislocation growing within a GaN nanorod is likely to be excluded by the strong image forces of the nearby free surfaces. Approximately 3000 nanorods were examined in cross-section, including growth through 50 and 80 nm diameter pores. The very few threading dislocations not filtered by the template turn toward a free surface within the nanorod, exiting less than 50 nm past the base of the template. The potential active region for light-emitting diode devices based on these nanorods would have been entirely free of threading dislocations for all samples examined. A greater than 2 orders of magnitude reduction in threading dislocation density can be surmised from a data set of this size. A finite element-based implementation of the eigenstrain model was employed to corroborate the experimentally observed data and examine a larger range of potential nanorod geometries, providing a simple map of the different regimes of dislocation filtering for this class of GaN nanorods. These results indicate that nanostructured semiconductor materials are effective at eliminating deleterious extended defects, as necessary to enhance the optoelectronic performance and device lifetimes compared to conventional planar heterostructures.
As lipopolysaccharide (LPS) is closely associated with
sepsis and
other life-threatening conditions, the point-of-care (POC) detection
of LPS is of significant importance to human health. In this work,
we illustrate an electrochemical aptasensor for the POC detection
of low-abundance LPS by utilizing boronate affinity (BA) as a simple,
efficient, and cost-effective amplification strategy. Briefly, the
BA-amplified electrochemical aptasensing of LPS involves the tethering
of the aptamer receptors and the BA-mediated direct decoration of
LPS with redox signal tags. As the polysaccharide chain of LPS contains
hundreds of cis-diol sites, the covalent crosslinking
between the phenylboronic acid group and cis-diol
sites can be harnessed for the site-specific decoration of each LPS
with hundreds of redox signal tags, thereby enabling amplified detection.
As it involves only a single-step operation (∼15 min), the
BA-mediated signal amplification holds the significant advantages
of unrivaled simplicity, rapidness, and cost-effectiveness over the
conventional nanomaterial- and enzyme-based strategies. The BA-amplified
electrochemical aptasensor has been successfully applied to specifically
detect LPS within 45 min, with a detection limit of 0.34 pg/mL. Moreover,
the clinical utility has been validated based on LPS detection in
complex serum samples. As a proof of concept, a portable device has
been developed to showcase the potential applicability of the BA-amplified
electrochemical LPS aptasensor in the POC testing. In view of its
simplicity, rapidness, and cost-effectiveness, the BA-amplified electrochemical
LPS aptasensor holds broad application prospects in the POC testing.
Our survey on gut and sputum microbiota revealed that both were significantly disturbed in non-small cell lung cancer (NSCLC) and associated with distant metastasis (DM) while only the sputum microbiota was associated with non-DM NSCLC. The lung microbiota could therefore have a stronger association with (and thus may contribute more to) disease development than the gut microbiota.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.